Cited by 40Lipoproteins and Cardiovascular HealthCholesterol and Lipid MetabolismLipid metabolism and disorders

Two apolipoprotein E5 variants illustrate the importance of the position of additional positive charge on receptor-binding activity

Open access
Wardell, MR, Rall, SC, Schaefer, EJ, Kane, JP, Weisgraber, KH·1991·Journal of Lipid Research

Abstract

Apolipoprotein (apo) E polymorphism has a significant effect on plasma cholesterol and low density lipoprotein cholesterol concentrations. The association of two apoE5 isoforms with elevated plasma low density lipoprotein cholesterol levels in two unrelated subjects led us to investigate the primary structures and receptor-binding properties of their apoE. Cysteamine modification and isoelectric focusing demonstrated that the apoE5 isoform from subject 1 did not contain cysteine but that the apoE5 isoform from subject 2 contained one residue of cysteine. The structural mutation in the apoE5 isoform of subject 1 was determined by peptide sequencing. Like apoE4, this variant had arginine at position 112 but differed from apoE4 by the substitution of arginine for proline at position 84. When purified and subjected to a competitive binding assay, this apoE5(84 Pro----Arg, 112 Cys----Arg) variant had the same receptor-binding activity as normal apoE3. Because subject 2 was of Japanese descent and her apoE5 contained one cysteine residue, we suspected that it would contain the lysine-forglutamic acid mutation at position 3 that has been described previously in Japanese subjects. This was confirmed by directly sequencing the first 10 amino acid residues of her apoE. When subjected to the competitive binding assay, the total apoE from subject 2, which consisted of approximately equal amounts of normal apoE3 and apoE5(3 Glu----Lys), had a binding activity of 188%, confirming the previously reported enhanced binding of this variant. These results demonstrate that the enhancement of receptor-binding activity of more basic isoforms of apoE depends on the position at which additional positively charged amino acids are incorporated.

Integrity signals

Registry

Crossref · 10.1016/s0022-2275(20)42076-0

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A few rare apo E variants (p.Glu21Lys, p.Pro102Arg, p.Leu270Glu) have been observed in probands with hyperLDLemia, but none co-segregated with hyperLDLemia in the families.

    “a few rare apo E variants (p.Glu21Lys, p.Pro102Arg and, p.Leu270Glu) have been observed in probands with hyperLDLemia (type IIa hyperlipoproteinemia), but none co-segregated with hyperLDLemia in the families (Wardell MR et al. 1991, van den Maagdenberg AM et al. 1993).”
  • The p.Arg269Gly apo E mutant has been previously reported in a proband with type IIb hyperlipoproteinemia, differing from ADH by elevated plasma triglyceride levels.

    “The p.Arg269Gly apo E mutant has been previously reported in a proband with type IIb hyperlipoproteinemia, differing from ADH by elevated plasma triglyceride levels (Wardell MR et al. 1991).”
  • APOE5 (Pro84Arg,Cys112Arg) heterozygosity was found in a 54-year-old woman of European descent with elevated LDL cholesterol levels.

    “Furthermore, APOE5 (Pro84Arg,Cys112Arg) heterozygosity was found in a 54-year-old woman of European descent with elevated LDL cholesterol levels113).”
  • The pathogenic mechanisms underlying HLP in patients with apoE5 (Glu3Lys) are presumed to involve downregulation of LDL receptors due to high uptake of lipoproteins containing this apoE mutant.

    “The pathogenic mechanisms underlying HLP in patients with apoE5 (Glu3Lys) are presumed to involve downregulation of low-density lipoprotein (LDL) receptors due to high uptake of lipoproteins containing this apoE mutant [10,11].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wardell, M., Rall, S., Schaefer, E., Kane, J., & Weisgraber, K.
Affiliations
University of California, San Francisco (US)
Venue
Journal of Lipid Research
Publisher
Elsevier BV
Published
1991-03
Volume
32
Issue
3
Pages
521-528
ISSN
0022-2275 (ISSN-L)
OpenAlex
W2138870569
Cited by
40
References
8
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2022: 2 · 2021: 2 · 2018: 2 · 2017: 2 · 2016: 1 · 2015: 2 · 2012: 1
FWCI
4.55
Type
journal article
Language
en
Open access
Locations
  • Journal of Lipid Research (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
National Heart, Lung, and Blood Institute (HL-41633, P01HL041633)
Topics
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords
apolipoprotein E, APOE polymorphism, receptor binding activity, cysteine substitution, arginine substitution, LDL cholesterol, serum cholesterol
MeSH terms
Amino Acids, Apolipoproteins E, Female, Humans, Isoelectric Focusing, Middle Aged, Polymorphism, Genetic, Receptors, Cell Surface, Low Density Lipoprotein Receptor-Related Protein-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review